港股異動 | 綠景中國地產(0095.HK)漲超40% 白石洲一期可售貨值超400億 料回籠大規模現金
格隆匯4月6日丨綠景中國地產(0095.HK)漲超40%,報1.49港元,總市值75億港元。該公司3月30日表示,深圳白石洲地價一期約18億,預期在本月初可以取得土地證,確保四證齊備,這對整個項目的推進是非常有正面影響的。白石洲一期現在地下施工正全面展開,土方已經基本結束。當前疫情反覆,對白石洲項目應該是影響是輕微的,沒有大的影響。按目前的施工進度來排,白石洲項目明年銷售在即。項目一期建築面積超過90萬平方米,權益佔比為80%,有將近33萬平方米屬於可售部分。從目前周邊項目批覆的限售價看,按單價13萬計,一期預計可售貨值超過400億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.